Fig. 1From: Role of bioactive fatty acids in nonalcoholic fatty liver diseaseBioactive fatty acid patterns according to nonalcoholic fatty liver disease (NAFLD) inhibtion and promotion. Key: The color bars tapering toward either side of the outcome line indicate a decline in activity of the NAFLD stage (orange) according to each fatty acid. The bioactive fatty acids panel includes SCFAs, MCFAs, and LCFAs. Key: NAFLD, nonalcoholic liver disease; SCFA, short-chain fatty acid; MCFA, medium-chain fatty acid; LCFA, long-chain fatty acidBack to article page